<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04748822</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02853-36</org_study_id>
    <nct_id>NCT04748822</nct_id>
  </id_info>
  <brief_title>Quality of Life in Patients With Alcohol Use Disorder</brief_title>
  <acronym>QUALIFACT</acronym>
  <official_title>Factors Associated With Quality of Life in Patients With Alcohol Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to investigate the factors associated with quality of&#xD;
      life of patients with alcohol use disorder (AUD) undergoing a detoxification program&#xD;
      (cross-sectional analysis). The secondary purpose is (1) to identify the factors associated&#xD;
      with change in quality of life between baseline and 6-month follow-up, and (2) to identify&#xD;
      the factors associated with alcohol relapse at 6 months (longitudinal analyses).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The standard DSM-5-based clinical assessment of AUD includes the number of AUD criteria&#xD;
      (between 2 and 11) as well as various parameters related to the patterns of alcohol use&#xD;
      (e.g., frequency of use, frequency of heavy use). In the contemporary clinical practice, more&#xD;
      &quot;functional&quot; assessment tools are emerging such as quality of life, autonomy, cognitive&#xD;
      functioning, but also other non-specific lifestyle habits, such as sleep quality and sexual&#xD;
      functioning. These indicators are important because they define the broad impact of AUD on&#xD;
      individual's life, and they are part of the overall rehabilitation, beyond the mere question&#xD;
      of the relationship to alcohol. However, the determinants of quality of life of patients with&#xD;
      AUD patients undergoing a detoxification program, and the factors associated with change in&#xD;
      quality of life are not well identified.&#xD;
&#xD;
      This prospective cohort study will recruit 200 patients undergoing a detoxification program&#xD;
      (home-based or in addiction services). Patients' demographic data, socioeconomic status,&#xD;
      physical diseases, medication use, clinical features of AUD, psychiatric variables,&#xD;
      impulsivity, autonomy, sexual functioning, sleep quality, and cognitive functioning will be&#xD;
      measured at baseline. The Alcohol Quality of Life Scale (AQoLS) will be completed at baseline&#xD;
      and at 6-month follow-up. Alcohol status (relapse/abstinence) will be assessed at 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective cohort study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life in patients with AUD.</measure>
    <time_frame>Within the 10th and 21st day of the detoxification program (baseline assessment).</time_frame>
    <description>Alcohol Quality of Life Scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life in patients with AUD 6 months after the detoxification program.</measure>
    <time_frame>6 months after the baseline assessment.</time_frame>
    <description>Alcohol Quality of Life Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol status</measure>
    <time_frame>6 months after the baseline assessment.</time_frame>
    <description>Alcohol (relapse/abstinence)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>Quality of life of patients with AUD.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients' demographic data, socioeconomic status, physical diseases, medication use, clinical features of AUD, psychiatric variables, impulsivity, autonomy, sexual functioning, sleep quality, and cognitive functioning will be measured at baseline. The Alcohol Quality of Life Scale (AQoLS) will be completed at baseline and at 6-month follow-up. Alcohol status (relapse/abstinence) will be assessed at 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>The Alcohol Quality of Life Scale (AQoLS) will be completed at baseline and at 6-month follow-up. Alcohol status (relapse/abstinence) will be assessed at 6 months.</description>
    <arm_group_label>Quality of life of patients with AUD.</arm_group_label>
    <other_name>Alcohol Quality of Life Scale (AQoLS) and Alcohol status</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DSM-5 AUD criteria&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  Within the 10th and 21st day of a detoxification program.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Communication difficulties (insufficient level of French, major hearing or visual&#xD;
             impairment, major cognitive deficit)&#xD;
&#xD;
          -  Under guardianship&#xD;
&#xD;
          -  Under justice control&#xD;
&#xD;
          -  Cannot be reached by phone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin ROLLAND, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH LE VINATIER</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LOUIS FERDINAND LESPINE, MD</last_name>
    <role>Study Director</role>
    <affiliation>CH LE VINATIER</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin ROLLAND, MD, PhD</last_name>
    <phone>+33 437 915 555</phone>
    <email>benjamin.rolland@ch-le-vinatier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Veronique VIAL</last_name>
    <phone>0033437915531</phone>
    <email>veronique.vial@ch-le-vinatier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Le Vinatier</name>
      <address>
        <city>Bron</city>
        <state>Auvergne Rhone Alpes</state>
        <zip>69678 cedex</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ROLLAND BENJAMIN, MD,Ph</last_name>
      <phone>0033 437 915 555</phone>
      <email>benjamin.rolland@ch-le-vinatier.fr</email>
    </contact>
    <contact_backup>
      <last_name>VIAL VERONIQUE</last_name>
      <phone>0033 437 915 531</phone>
      <email>veronique.vial@ch-le-vinatier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>February 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

